Pancreatic Cancer Research

Journal articleAm J Manag Care2019

Current treatment landscape and emerging therapies for pancreatic cancer.

Journal
Am J Manag Care
Published
1 January 2019
Citations
25
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Pancreatic cancer remains a disease that is difficult to treat due to a typically late presentation, relatively high resistance to chemotherapy, and lack of effective targeted therapies. The standard of care relies on cytotoxic chemotherapy, primarily FOLFIRINOX and gemcitabine-based regimens. … Excerpt only: this text is the publisher’s. Read it in full at the source.